|
# |
Nature/Brief Description |
Date |
Level*
C - Confidential
P - Public (Open or restricted) |
|
D-A2.1 |
Programme handbook for QA procedures
This handbook with outline the procedures for managing the Quality Assurance, reporting and financial administration procedures for the project.
UP |
4 |
C |
|
D-A3.2 |
Final programme report
The report should be an executive summary and will include a short state of the art concerning the influence of chronic and acute driver impairment factors and the main results and recommendations derived from the different work packages and workshops. Information about exploitation possibilities, possible users and contact addresses should also be part of this final report.
UP |
36+ |
P |
|
D-A3.8 |
Exploitation plan, collaborative agreement and IPR
This report should include the collaboration agreement, information about detection of impairment and practice in some countries, involved and responsible scientific disciplines. Existing EC directives and proposals for driver assessment. Proposals for new strategies of political, police and authorities work. Range of applications and new methods of detecting impairment. Aspects of quality assurance of different professions and technical equipment. Proposals for timing of exploitation and actions.
UP |
4/12/20 |
C |
|
D-R1.1 |
Impairments, diseases, age and their relative risks of accident involvement
Literature review of impairment and accident risk associated with ageing, illness and disease. The deliverable will document the results from task R.1.1, which consists of an updated literature review and metaanalyses of health-related risk factors. The analyses will partly be based on research reports compiled for the Norwegian Traffic Safety Handbook.
UP |
13 |
P |
|
D-R1.2 |
Driver health and crash involvement
The deliverable is a documentation of the work in task R1.2, which is a questionnaire-based study of self-reported health problems among crash-involved drivers. This will suggest health factors related to accident involvement.
UP |
24 |
P |
|
D-R1.4 |
Medical condition and fitness to drive
The deliverable contains results from the prospective analysis carried out on 4000 drivers attending Medical-Psychological Centres for assessment of fitness to drive of drivers obtaining/renewing driving licence to predict licensing assessment and subsequent traffic violations and accidents.
UP |
28 |
P |
|
D-R1.5 |
Effects of depression and antidepressant therapy on driving performance
This report will describe the study to measure the effects of antidepressants and depression severity on cognition, psychomotor function and driving performance of depressed outpatients during 6-8 weeks of subchronic drug treatment by means of laboratory performance tests and standardized actual driving tests respectively. Depression severity will by assessed by means of clinical rating scales. Patients’ driving performance throughout treatment will be evaluated with respect to their baseline performance prior to initiation of therapy. In addition the patients’ driving performance will be evaluated against a normative database of ‘normal’ driving performance in the general population. The latter is an historical data base containing driving performance of healthy volunteers in the same standard driving tests under placebo conditions in previous driving studies (i.e > 40) conducted by UM_BBI. This normative database can ultimately be used for evaluating individual driving performance regardless of his/her mental state and/or medication use.
UP |
28 |
P |
|
D-R1.6 |
Effect of diabetes mellitus on driving performance and relation to fatigue and alcohol effect
Results of survey and experiment will be summarised to description of relations between physical disorder (diabetes) and psychic disability and of its effect on safety or risky driving. This will develop a list of risky factors in dependence on various conditions, as the age, gender, practice, severity of the illness, medication, keeping of regime and diet. These results will be processed to recommendations concerning diagnostic and rehabilitation methods, norms and proposals for legislation of EU an associated countries, especially from the centre and the west of Europe, because CDV has good contacts to them. Also, principles of safe driving will be formulated for diabetes patients and common knowledge of diabetes problems for "healthy" drivers population.
UP |
24 |
P |
|
D-R1.7 |
Development of licensing assessment protocols for elderly drivers with Arthritis
This report will recognise that whereas many countries do have licensing restrictions, the methods of testing used to determine the form of restriction are seldom standardised or validated. The reported study will consider road, simulator and computer-based methods of assessment in terms of standardised protocols for specific categories of driver disability related to age. The results presented in this result will suggest the validity of such methods as assessment tools and guidelines for application.
UP |
28 |
P |
|
D-R1.8 |
Assessment of fitness-to-drive amongst patients with learning difficulties
This report will provide a detailed description of the developed assessment methods, experimental design, results and conclusions regarding the potential and feasibility of medical assessment, neuropsychological assessment simulator assessment and on-road assessment methods used in fitness to drive evaluations of persons with learning difficulties. This will include an inventory of promising assessment methods or combination of methods, discussion of assessment methods and tolerance levels for impairment related to ADHD syndrome patients driving with and without medication as well as different levels and types of learning difficulty associated with light mental retardation.
UP |
28 |
P |
|
D-R1.9 |
Ageing, illness and disease: A synthesis of results
The report will be a synthesis report of the main findings of the various studies included in R1, as well as recommendations for further actions, including suggestions for "tolerance levels" applicable to licensing assessments.
UP |
30 |
P |
|
D-R4.1 |
Review of impairment and accident risk for alcohol, drugs and medicines
This report will be an introduction into the problem of drugged drivers and the impact of different substances on driving performance. Recent results of scientific research on this topic and possibilities of detection of drugged drivers and driver assessment.
UP |
6 |
P |
|
D-R4.2 |
The prevalence of drug driving and relative risk estimations. A study conducted in The Netherlands, Norway and the United Kingdom
The deliverable will contain a presentation of the R4.2 study indicating the prevalence of substances in drivers from the roadside surveys carried out in three countries (Norway, Netherlands, UK). The comparison of incidence rates from fatal and baseline cases should suggest risk factors for different substance categories. Where possible, tolerance levels will be specified from analyses of dose-equivalent effects. This will include results on roadside impairment testing from the parallel task R4.5a.
UP |
28 |
P |
|
D-R4.3 |
Drugs in accident involved drivers in Denmark
This will provide a discussion of a qualitative analysis of accident causal factors related to impaired drivers, by means of anonymous in-depth interviews of the parties in such accidents, carried out in co-operation with physicians at selected hospitals.
UP |
28 |
P |
|
D-R4.4 |
Experimental studies on the effects of licit and illicit drugs on driving performance, psychomotor skills and cognitive function
This report will describe two experimental series of studies. The first study aims to assess the effects of MDMA on actual driving performance, cognition and psychomotor function of recreational MDMA users as a function of dose and time after dosing. This study will be designed to assess the effects of MDMA with and without a social dose of alcohol. The second study will assess the effect of flu medications on driving and cognitive performance in conjunction with fatigue. This report will summarise the extent of safety risk from these types of drug impairment.
UP |
28 |
P |
|
D-R4.6 |
Drugs and alcohol in traffic – A Synthesis of Results
This will be a summary report from results in R4.
UP |
30 |
P |
|
D-P2 |
Detailed cost-benefit analysis of potential impairment countermeasures.
This will contain: an inventory of promising measures against chronic and acute impairment factors covered in the research packages; estimations of costs, intended effects and side effects of these measures based on existing knowledge; assessment of monetary values of these effects, as far as possible given the state of knowledge; discussion of the other aspects that are relevant for decision makers (like the weights they assign to the various effects and the fairness of their distribution among road users); assessment of the social profitability of the measures (Benefit/Cost ratio's) and a ranking of measures.
UP |
34 |
|
|
D-P4.1 |
Report on Workshop 1 ”Vision and perceptual deficiencies as a risk factor in traffic safety”
A summary of the presentations and discussions with experts and users about the draft D-R1.1 and D-R4.1; conclusions on vision/perception related problems of ageing, illness, medicines etc. related to risk in traffic and its application by decision makers.
UP |
18 |
P |
|
D-P4.2 |
Fatigue, sleepiness and reduced alertness as risk factors in driving
The deliverable will summarise presentations and discussions from workshop P4.2. Possible policy implications of knowledge about fatigue as a risk factor in road traffic will be pointed out, as well as priority areas for future research.
UP |
22 |
P |
|
D-P4.3 |
The use and usability of CD 91/439 on Driving Licensing
A summary of the presentations and discussions with experts and users about the use and usability of CD 91/439 on driving licensing, as well as about deliverables from R1, R4 and P related to the same topic. Presentation of main conclusions and its application by decision makers.
UP |
30 |
P |
|
D-P4.4 |
Proceedings of 4th workshop ”Cost benefit analysis on impairment countermeasures”
Report on CBA policy workshop. A summary of the presentations and discussions with experts and users about the draft CBA D-P 3; conclusions on the final CBA and its application by decision makers.
UP |
34 |
P |
|
D-P8 |
Policy synthesis report
A summary of the workshop conclusions (P4.1-P4.4) and CBA work on potential impairment countermeasures, tolerance levels, age limits for driving etc as well as the potential and feasibility of roadside testing for acute and chronic impairment and its application by decision makers in Policy development.
UP |
36 |
P |
beneath! The reports are available as zipped *.Pdf-Files!
